Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Cobimetinib
Medication labelCOTELLIC ® is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, in…
Why this: Advisory · dailymed-prescription
COTELLIC ® is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, in combination with vemurafenib. COTELLIC®, as a single agent, is indicated for the treatment of adult patients with histiocytic neoplasms.
- generic_name
- cobimetinib
- product_names
- COBIMETINIB
- ndc
- 50242-717, 50242-717-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en